-- Fotona, a Slovenian medical laser company founded in 1964, is reporting a significant rise in Fotona4D bookings among patients in their 20s and 30s across major U.S. cities, as collagen banking, the practice of investing in collagen stimulation before visible aging appears, solidifies its position as the defining aesthetic priority of 2026. The trend signals a generational departure from the volume-first injectable approach that dominated the previous decade, with younger patients seeking treatments that work with the body's own biology rather than augmenting it externally.
Where prior generations waited for visible signs of aging before seeking treatment, this cohort is arriving earlier. The question has shifted from how to correct what has already changed to how to preserve what they currently have. Clinics offering Fotona4D report that patients in their 20s now represent a meaningful and growing segment of their booking base, a demographic shift that would have been uncommon in aesthetic medicine as recently as five years ago.
"What we are seeing is a fundamental reset in how younger patients think about their skin," said Aimee Desrosiers, Fotona CMO with 30 years of trend forecasting experience. "They are not waiting for a problem to appear. They are building a biological reserve now, and Fotona4D gives them a clinically credible way to do that without needles or downtime."
The booking surge arrives against a broader backdrop of growing patient skepticism toward dermal fillers. A pattern widely referenced in aesthetic medicine as filler fatigue has accelerated since 2022, driven by social media documentation of filler migration, altered facial proportions, and the long-term consequences of volume accumulation. The global aesthetic medicine market is projected to exceed $30 billion by 2031, with non-invasive, biology-forward treatments accounting for a rising share of that growth, according to industry analysts tracking the category.
Fotona4D addresses this demand through a four-stage protocol that treats the skin at multiple depths in a single session. Treatment begins inside the mouth, where a specialized handpiece delivers laser energy to the jawline and perioral region, producing a natural lift and softening expression lines including nasolabial folds without injectable volume. The second stage targets deeper imperfections and pigmentation to restore a more uniform complexion. A third stage applies controlled heating across the full face to produce a firming and lifting effect. The fourth stage delivers a light laser peel to refine surface texture and address visible irregularities. No needles are used at any stage and most patients resume normal activity the same day.
The treatment also addresses signs of aging around the eye area, including lid laxity, forehead laxity, fine lines, and dark circles, using the body's own collagen-building mechanisms rather than external augmentation, a clinical capability that distinguishes Fotona4D from competing energy-based devices in its category.
"The industry spent years teaching patients to want volume," Desrosiers said. "We are now in the business of teaching them to want something better. For a generation that has grown up watching the consequences of overdone aesthetics play out in real time, that conversation is not a hard one to start."
Physicians and clinic owners seeking information on incorporating Fotona4D into their practice can visitFotona for clinical documentation, training resources, and global contact information.
About Fotona
Fotona is a medical laser company headquartered in Ljubljana, Slovenia, with more than 60 years of experience developing laser systems for dermatology, gynecology, dentistry, and surgical medicine. Its devices are in active clinical use across more than 130 countries. Fotona4D is a proprietary four-stage treatment protocol developed using the company's dual-wavelength laser platform, addressing skin laxity, collagen depletion, pigmentation, and surface texture in a single session without injectables or surgical intervention.
Contact Info:
Name: Aimee Desrosiers, Chief Marketing Officer
Email: Send Email
Organization: Fotona
Website: https://www.fotona.com
Release ID: 89196844
Google
RSS